Emerging studies suggest this peptide, a dual agonist targeting both the gut-brain axis and GIP , appears to offer a promising advancement for weight management . Preliminary human investigations have shown considerable decreases in abdominal fat , conceivably exceeding other weight-loss medications . However , further assessment is needed to thoro